Nevro Corp (NVRO)
Nevro is a medical device company focused on delivering solutions for patient with pain treatment. Co. has developed and commercialized the Senza® spinal cord stimulation (SCS) system, a neuromodulation platform for the treatment of chronic pain, with the Senza® Omnia platform being an addition to the Senza family of products. Co.'s proprietary, paresthesia-free 10 kHz Therapy, delivered by its Senza system is designed to treat back pain and leg pain. In addition, Co. received approval of unilateral or bilateral pain, associated with painful diabetic neuropathy and expanded labeling in non-surgical refractory back pain.
NVRO SEC Filing Email Alerts Service
Company Name: |
Nevro Corp |
Website: |
www.nevro.com |
Sector: |
Medical Instruments & Supplies |
Number of ETFs Holding NVRO: |
27 |
Total Market Value Held by ETFs: |
$74.24M |
Total Market Capitalization: |
$494.00M |
% of Market Cap. Held by ETFs: |
15.03% |
|
|
March 29, 2024 6:55 AM Eastern
Hold (1.87 out of 4)
0th percentile
|
|